| HOME >> MEDICINE >> TECHNOLOGY |
Krishna Kumar, MB, BS
Regina Qu'appelle Health Region
Regina, Saskatchewan
Michael Leong, MD
Chief at Stanford Pain Management Center
Stanford, CA
Liong Liem, MD, FIPP
St. Antonius Hospital
Utrecht, Netherlands
Gladstone McDowell II, MD
CEO/Medical Director, Integrated Pain Solutions
Columbus, OH
Nagy Mekhail, MD, PhD
Cleveland Clinic
Cleveland, OH
Sunil Panchal, MD
National Institute of Pain
Tampa, FL
James P. Rathmell, MD
Harvard Medical School
Boston, MA
Richard Rauck, MD, FIPP
Carolinas Pain Institute
Winston-Salem, NC
Peter Staats, MD, MBA
Metzer Staats Pain Management
Manalapan, NJ
Michael Saulino, MD, PhD
MossRehab
Voorhees, NJ
B. Todd Sitzman, MD, MPH
Advanced Pain Therapy, PLLC
Hattiesburg, MS
Michael Stanton-Hicks, MD
Center for Neurological Restoration, Cleveland Clinic
Cleveland, OH
Lisa Jo Stearns, MD
Center for Pain and Supportive Care
Scottsdale, AZ
Mark Steven Wallace, MD
University of California, San Diego Health System
San Diego, CA
K. Dean Willis, MD
Alabama Pain Center and Alabama Fibromyalgia Center
Huntsville, AL
William O. Witt, MD
University of Kentucky
Lexington, KY
Tony Yaksh, PhD
University of California, San Diego
San Diego, CA
About Azur Pharma
Azur Pharma is a privately held pharmaceutical company dedicated to enhancing patients' lives by developing and marketing pharmaceutical products in specialist therapeutic areas. Azur's strategy is to identify, evaluate, selectively acquire and enhance the value of late stage development and approved pharmaceutical products. (website: www.azurpharma.com)
About PRIALT(R) (ziconotide intrathecal infusion)
'/>"/>
| SOURCE Azur Pharma, Inc. Copyright©2010 PR Newswire. All rights reserved |